The Value of Vedolizumab as Rescue Therapy in Moderate-Severe Crohn's Disease Patients with Adalimumab Non-response in the USA. [electronic resource]
Producer: 20160502Description: 669-75 p. digitalISSN:- 1876-4479
- Adalimumab -- economics
- Anti-Inflammatory Agents -- economics
- Antibodies, Monoclonal, Humanized -- economics
- Computer Simulation
- Crohn Disease -- drug therapy
- Drug Administration Schedule
- Drug Costs -- statistics & numerical data
- Drug Therapy, Combination
- Humans
- Markov Chains
- Models, Biological
- Models, Economic
- Models, Statistical
- Quality of Life
- Severity of Illness Index
- Treatment Failure
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.